Legal & General Group PLC Akouos, Inc. Transaction History

Legal & General Group PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.6 - $5.16 $5,192 - $10,304	-1,997 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$7.65 - $11.38 $23,347 - $34,731	-3,052 Reduced 60.45%	1,997 $17,000
Q3 2021 Nov 15, 2021	BUY	$9.93 - $13.59 $30,306 - $41,476	3,052 Added 152.83%	5,049 $59,000
Q2 2021 Aug 12, 2021	SELL	$11.87 - $15.96 $5,935 - $7,980	-500 Reduced 20.02%	1,997 $25,000
Q1 2021 May 17, 2021	BUY	$13.87 - $21.04 $12,247 - $18,578	883 Added 54.71%	2,497 $35,000
Q3 2020 Nov 13, 2020	BUY	$19.3 - $26.92 $21,654 - $30,204	1,122 Added 228.05%	1,614 $37,000
Q2 2020 Aug 14, 2020	BUY	$22.0 - $22.5 $10,824 - $11,070	492 New	492 $11,000

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.